SUV39H1
MOLECULAR TARGETSUV39H1 histone lysine methyltransferase
SUV39H1 (SUV39H1 histone lysine methyltransferase) is targeted by 5 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting SUV39H1
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | chaetocin | 2.94 | 18 |
| 2 | chetomin | 1.95 | 6 |
| 3 | s adenosylhomocysteine | 1.10 | 2 |
| 4 | Cyproheptadine | 0.69 | 1 |
| 5 | Gliotoxin | 0.69 | 1 |
About SUV39H1 as a Drug Target
SUV39H1 (SUV39H1 histone lysine methyltransferase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 5 compounds with documented SUV39H1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
SUV39H1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.